183 related articles for article (PubMed ID: 34003826)
21. Survival in patients with uveal melanoma in Europe.
Virgili G; Gatta G; Ciccolallo L; Capocaccia R; Biggeri A; Crocetti E; Lutz JM; Paci E;
Arch Ophthalmol; 2008 Oct; 126(10):1413-8. PubMed ID: 18852420
[TBL] [Abstract][Full Text] [Related]
22. Surgery vs. radiotherapy in patients with uveal melanoma : Analysis of the SEER database using propensity score matching and weighting.
Jang BS; Chang JH; Oh S; Lim YJ; Kim IH
Strahlenther Onkol; 2017 Nov; 193(11):931-942. PubMed ID: 28879443
[TBL] [Abstract][Full Text] [Related]
23. American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients.
Shields CL; Kaliki S; Furuta M; Fulco E; Alarcon C; Shields JA
Ophthalmology; 2013 Oct; 120(10):2066-71. PubMed ID: 23664467
[TBL] [Abstract][Full Text] [Related]
24. Second Primary Neoplasms in Patients With Uveal Melanoma: A SEER Database Analysis.
Laíns I; Bartosch C; Mondim V; Healy B; Kim IK; Husain D; Miller JW
Am J Ophthalmol; 2016 May; 165():54-64. PubMed ID: 26940164
[TBL] [Abstract][Full Text] [Related]
25. Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma.
Lane AM; Kim IK; Gragoudas ES
JAMA Ophthalmol; 2018 Sep; 136(9):981-986. PubMed ID: 29955797
[TBL] [Abstract][Full Text] [Related]
26. Uveal melanoma in young patients.
Singh AD; Shields CL; Shields JA; Sato T
Arch Ophthalmol; 2000 Jul; 118(7):918-23. PubMed ID: 10900104
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Metastatic Risk after Biopsy of Posterior Uveal Melanoma.
Bagger M; Smidt-Nielsen I; Andersen MK; Jensen PK; Heegaard S; Andersen KK; Friis S; Kiilgaard JF
Ophthalmology; 2018 Dec; 125(12):1969-1976. PubMed ID: 29705056
[TBL] [Abstract][Full Text] [Related]
28. Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.
Caujolle JP; Paoli V; Chamorey E; Maschi C; Baillif S; Herault J; Gastaud P; Hannoun-Levi JM
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1218-24. PubMed ID: 23177670
[TBL] [Abstract][Full Text] [Related]
29. Delayed systemic recurrence of uveal melanoma.
Kolandjian NA; Wei C; Patel SP; Richard JL; Dett T; Papadopoulos NE; Bedikian AY
Am J Clin Oncol; 2013 Oct; 36(5):443-9. PubMed ID: 22706174
[TBL] [Abstract][Full Text] [Related]
30. International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification.
Stang A; Parkin DM; Ferlay J; Jöckel KH
Int J Cancer; 2005 Mar; 114(1):114-23. PubMed ID: 15523698
[TBL] [Abstract][Full Text] [Related]
31. Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.
Kuk D; Shoushtari AN; Barker CA; Panageas KS; Munhoz RR; Momtaz P; Ariyan CE; Brady MS; Coit DG; Bogatch K; Callahan MK; Wolchok JD; Carvajal RD; Postow MA
Oncologist; 2016 Jul; 21(7):848-54. PubMed ID: 27286787
[TBL] [Abstract][Full Text] [Related]
32. International Validation of the American Joint Committee on Cancer's 7th Edition Classification of Uveal Melanoma.
AJCC Ophthalmic Oncology Task Force
JAMA Ophthalmol; 2015 Apr; 133(4):376-83. PubMed ID: 25555246
[TBL] [Abstract][Full Text] [Related]
33. A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes.
Binkley E; Triozzi PL; Rybicki L; Achberger S; Aldrich W; Singh A
Br J Ophthalmol; 2020 Apr; 104(4):524-528. PubMed ID: 31371315
[TBL] [Abstract][Full Text] [Related]
34. Clinical predictors of survival in metastatic uveal melanoma.
Lorenzo D; Piulats JM; Ochoa M; Arias L; Gutiérrez C; Català J; Cobos E; Garcia-Bru P; Dias B; Padrón-Pérez N; Caminal JM
Jpn J Ophthalmol; 2019 Mar; 63(2):197-209. PubMed ID: 30796549
[TBL] [Abstract][Full Text] [Related]
35. UVEAL METASTASIS BASED ON PATIENT AGE IN 1,111 PATIENTS: Comparison of Clinical Features and Outcomes Per Age Category.
Shields CL; Acaba-Berrocal LA; Selzer EB; Mayro EL; Newman JH; Malik K; Welch RJ; Shields JA
Retina; 2020 Feb; 40(2):204-213. PubMed ID: 31972789
[TBL] [Abstract][Full Text] [Related]
36. American Joint Committee on Cancer Classification of Uveal Melanoma (Anatomic Stage) Predicts Prognosis in 7,731 Patients: The 2013 Zimmerman Lecture.
Shields CL; Kaliki S; Furuta M; Fulco E; Alarcon C; Shields JA
Ophthalmology; 2015 Jun; 122(6):1180-6. PubMed ID: 25813452
[TBL] [Abstract][Full Text] [Related]
37. Variates of survival in metastatic uveal melanoma.
Rietschel P; Panageas KS; Hanlon C; Patel A; Abramson DH; Chapman PB
J Clin Oncol; 2005 Nov; 23(31):8076-80. PubMed ID: 16258106
[TBL] [Abstract][Full Text] [Related]
38. [Age distribution of uveal melanoma and its relationship to survival].
Graell X; Caminal JM; Masuet C; Arias L; Rubio M; Pujol O; Roca G; Arruga J
Arch Soc Esp Oftalmol; 2007 Jun; 82(6):343-7. PubMed ID: 17573643
[TBL] [Abstract][Full Text] [Related]
39. Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes.
Shields CL; Kaliki S; Livesey M; Walker B; Garoon R; Bucci M; Feinstein E; Pesch A; Gonzalez C; Lally SE; Mashayekhi A; Shields JA
JAMA Ophthalmol; 2013 Aug; 131(8):993-1003. PubMed ID: 23681424
[TBL] [Abstract][Full Text] [Related]
40. Retrospective evaluation of patients with uveal melanoma treated by stereotactic radiosurgery with and without tumor resection.
Suesskind D; Scheiderbauer J; Buchgeister M; Partsch M; Budach W; Bartz-Schmidt KU; Ritz R; Grisanti S; Paulsen F
JAMA Ophthalmol; 2013 May; 131(5):630-7. PubMed ID: 23494018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]